UA85377C2 - Use of composition containing hpv16 and hpv18 viral particles in preparation o medication for prevention of infection and/or desease caused by group of oncogenic hpv types, methods for inducing of immune reaction, prevention of infection and/or desease, prevention in subject population of infection caused by ome or more groups of oncogenic hpv types, vaccine composition containing hpv16 and нpv18 - Google Patents
Use of composition containing hpv16 and hpv18 viral particles in preparation o medication for prevention of infection and/or desease caused by group of oncogenic hpv types, methods for inducing of immune reaction, prevention of infection and/or desease, prevention in subject population of infection caused by ome or more groups of oncogenic hpv types, vaccine composition containing hpv16 and нpv18Info
- Publication number
- UA85377C2 UA85377C2 UAA200505919A UA2005005919A UA85377C2 UA 85377 C2 UA85377 C2 UA 85377C2 UA A200505919 A UAA200505919 A UA A200505919A UA 2005005919 A UA2005005919 A UA 2005005919A UA 85377 C2 UA85377 C2 UA 85377C2
- Authority
- UA
- Ukraine
- Prior art keywords
- prevention
- infection
- hpv types
- composition containing
- caused
- Prior art date
Links
Abstract
The invention relates to the use of a composition containing HPV16 and HPV18 viral paricles in preparation of a medication for prevention of infection and/or disease caused by the group of oncogenic HPV types as well to methods for inducing of immune reaction against one or more groups of oncogenic HPV types, prevention of infection and/or disease, caused by one or more groups of oncogenic HPV types, and prevention in the subject population of infection caused by one or more groups of oncogenic HPV types. The invention also relates to a vaccine composition containing HPV16 and HPV18 viral paricles and provides for cross protection against the infection and/or disease caused by the group of oncogenic HPV types.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43503502P | 2002-12-20 | 2002-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA85377C2 true UA85377C2 (en) | 2009-01-26 |
Family
ID=36166935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200505919A UA85377C2 (en) | 2002-12-20 | 2003-12-18 | Use of composition containing hpv16 and hpv18 viral particles in preparation o medication for prevention of infection and/or desease caused by group of oncogenic hpv types, methods for inducing of immune reaction, prevention of infection and/or desease, prevention in subject population of infection caused by ome or more groups of oncogenic hpv types, vaccine composition containing hpv16 and нpv18 |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN100418577C (en) |
| SI (1) | SI1572233T1 (en) |
| UA (1) | UA85377C2 (en) |
| ZA (1) | ZA200504907B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101116745B (en) * | 2006-08-04 | 2011-05-11 | 长春百克生物科技股份公司 | Human papilloma virus sample particle vaccines |
| CN101181636B (en) * | 2006-11-14 | 2010-09-15 | 北京金迪克生物技术研究所 | Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof |
| TR201802597T4 (en) * | 2009-06-19 | 2018-03-21 | Eyegene Inc | Vaccine for cervical cancer. |
| CN102349996B (en) * | 2011-10-17 | 2014-06-25 | 沈阳三生制药有限责任公司 | Human papilloma virus pharmaceutical composition and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
-
2003
- 2003-12-18 UA UAA200505919A patent/UA85377C2/en unknown
- 2003-12-18 CN CNB2003801097292A patent/CN100418577C/en not_active Expired - Lifetime
- 2003-12-18 SI SI200332003T patent/SI1572233T1/en unknown
-
2005
- 2005-06-15 ZA ZA200504907A patent/ZA200504907B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1572233T1 (en) | 2011-07-29 |
| CN1747745A (en) | 2006-03-15 |
| CN100418577C (en) | 2008-09-17 |
| ZA200504907B (en) | 2006-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1872A (en) | Virus-like particles of human papillomavirus. | |
| MA33449B1 (en) | RECOMBINANT ANTIGENS OF THE VRS | |
| EP1618889B8 (en) | Influenza Vaccine | |
| IL207468A (en) | Hcv inhibitors and use thereof for the preparation of medicaments for treatment of hcv infections | |
| IL172189A0 (en) | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases | |
| MY144492A (en) | Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types | |
| DE60334205D1 (en) | Heterocyclische sulfonamid-hepatitis-c-virus-hemmer | |
| MY140664A (en) | Optimized expression of hpv 45 l1 in yeast | |
| MX2010001733A (en) | Imidazopyrazine compounds. | |
| HK1044799A1 (en) | Immunoligically significant herpes simplex virus antigens | |
| EP1246644A4 (en) | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| NO965590D0 (en) | Papillomavirus polynucleotide vaccine | |
| EP2708549A3 (en) | Improved vaccines and methods for using the same | |
| WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
| WO2005028496A3 (en) | Vaccine for treatment and prevention of herpes simplex virus infection | |
| WO2002032942A3 (en) | Compositions and methods for modulating rsv infection and immunity | |
| MXPA02007271A (en) | Pyrrole type compounds, compositions, and methods for treating cancer or viral diseases. | |
| GEP20084377B (en) | Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections | |
| WO2000057909A3 (en) | Attenuated dengue-2 virus vaccine | |
| UA85377C2 (en) | Use of composition containing hpv16 and hpv18 viral particles in preparation o medication for prevention of infection and/or desease caused by group of oncogenic hpv types, methods for inducing of immune reaction, prevention of infection and/or desease, prevention in subject population of infection caused by ome or more groups of oncogenic hpv types, vaccine composition containing hpv16 and нpv18 | |
| TW200612983A (en) | Vaccine | |
| WO2000057908A3 (en) | Attenuated dengue-1 virus vaccine | |
| WO2000057904A3 (en) | Attenuated dengue-3 virus vaccine | |
| WO2003026693A3 (en) | Inhibitors of costimulation by 0x40 and their use against infectious diseases |